AstraZeneca Dividends
Dividend/share amount | Ex-dividend Date | Payment Date | Dividend Yield | |
---|---|---|---|---|
Next Dividend | £0.776 | 8/8/24 | 9/9/24 |
N/A |
Last Dividend | £1.56 | 2/22/24 | 3/25/24 | N/A |
The next AstraZeneca dividend is expected soon, leave us your email to let you know.
AstraZeneca Dividend Calendar
Event | Day |
---|---|
Last trading date | August 7, 2024 |
Ex-date | August 8, 2024 |
Record date | August 9, 2024 |
Payable date | September 9, 2024 |
AstraZeneca dividend history
Ex-Date | Amount | Variation | Div. Yield |
---|---|---|---|
2024 | £156 | 33.50% | 1.55% |
2/22/24 | £156 | 1.55% | |
2023 | £234.600006 | 5.82% | 2.10% |
8/10/23 | £71.800003 | 0.64% | |
2/23/23 | £162.800003 | 1.45% | |
2022 | £221.700005 | 9.64% | 2.32% |
8/11/22 | £76.400002 | 0.73% | |
2/24/22 | £145.300003 | 1.69% | |
2021 | £202.199997 | 6.39% | 2.64% |
8/12/21 | £64.800003 | 0.78% | |
2/25/21 | £137.399994 | 1.96% | |
2020 | £215.999992 | 1.23% | 2.75% |
8/13/20 | £69.599998 | 0.81% | |
2/27/20 | £146.399994 | 2.05% | |
2019 | £218.700005 | 8.27% | 3.27% |
8/8/19 | £71.900002 | 0.99% | |
2/28/19 | £146.800003 | 2.39% | |
2018 | £202.000008 | 7.80% | 3.74% |
8/9/18 | £68.400002 | 1.13% | |
2/15/18 | £133.600006 | 2.83% | |
2017 | £219.099999 | 9.71% | 4.90% |
8/10/17 | £68.900002 | 1.56% | |
2/16/17 | £150.199997 | 3.32% | |
2016 | £199.699997 | 9.42% | 4.30% |
8/11/16 | £68.699997 | 1.33% | |
2/18/16 | £131 | 3.17% | |
2015 | £182.5 | 7.42% | 4.19% |
8/13/15 | £57.5 | 1.35% | |
2/19/15 | £125 | 2.82% | |
2014 | £169.900001 | 5.45% | 4.20% |
8/13/14 | £53.099998 | 1.29% | |
2/19/14 | £116.800003 | 2.93% | |
2013 | £179.700001 | 1.10% | 5.80% |
8/14/13 | £59.200001 | 1.82% | |
2/13/13 | £120.5 | 4.08% | |
2012 | £181.699996 | 7.77% | 6.15% |
8/8/12 | £58.099998 | 1.93% | |
2/15/12 | £123.599998 | 4.27% | |
2011 | £168.599999 | 12.18% | 5.88% |
8/3/11 | £51.900002 | 1.86% | |
2/2/11 | £116.699997 | 3.96% | |
2010 | £150.300004 | 6.75% | 4.96% |
8/4/10 | £44.900002 | 1.39% | |
2/3/10 | £105.400002 | 3.73% | |
2009 | £140.800003 | 47.43% | 5.24% |
8/5/09 | £36 | 1.31% | |
2/4/09 | £104.800003 | 4.00% | |
2008 | £95.499996 | 8.15% | 4.18% |
8/6/08 | £27.799999 | 1.09% | |
2/6/08 | £67.699997 | 3.34% | |
2007 | £88.299999 | 12.63% | 3.23% |
8/8/07 | £25.299999 | 1.01% | |
2/7/07 | £63 | 2.14% | |
2006 | £78.399999 | 39.50% | 2.68% |
8/9/06 | £26.6 | 0.83% | |
2/8/06 | £51.799999 | 1.96% | |
2005 | £56.199999 | 23.79% | 2.39% |
8/10/05 | £21.9 | 0.85% | |
2/9/05 | £34.299999 | 1.62% | |
2004 | £45.4 | 3.30% | 1.85% |
8/11/04 | £16 | 0.67% | |
2/18/04 | £29.4 | 1.16% | |
2003 | £43.95 | 8.25% | 1.89% |
8/20/03 | £15.45 | 0.62% | |
2/19/03 | £28.5 | 1.33% | |
2002 | £47.900001 | 0.71% | 1.77% |
8/21/02 | £14.7 | 0.75% | |
2/20/02 | £33.200001 | 0.96% | |
2001 | £47.559999 | 7.14% | 1.48% |
8/22/01 | £16.1 | 0.49% | |
2/21/01 | £31.459999 | 1.00% | |
2000 | £44.39 | 5.19% | 1.68% |
9/4/00 | £15.29 | 0.49% | |
3/6/00 | £29.1 | 1.36% | |
1999 | £42.2 | 8.21% | 1.62% |
9/6/99 | £14.2 | 0.58% | |
3/29/99 | £28 | 1.01% | |
1998 | £39 | 8.33% | 1.63% |
9/14/98 | £14 | 0.62% | |
3/16/98 | £25 | 0.99% | |
1997 | £36 | 11.63% | 2.01% |
9/15/97 | £13.5 | 0.74% | |
3/17/97 | £22.5 | 1.29% | |
1996 | £32.25 | 11.21% | 2.27% |
9/16/96 | £12.5 | 0.83% | |
3/18/96 | £19.75 | 1.47% | |
1995 | £29 | 4.50% | 3.07% |
9/18/95 | £11.25 | 1.06% | |
3/13/95 | £17.75 | 2.16% | |
1994 | £27.75 | 164.29% | 3.64% |
9/12/94 | £10.75 | 1.34% | |
3/14/94 | £17 | 2.36% | |
1993 | £10.5 | 1.50% | |
9/20/93 | £10.5 | 1.50% |
AstraZeneca Dividend Analysis
AstraZeneca FAQ
AstraZeneca will reward its shareholders with a dividend of £0.776 per share, which represents a yield of 0.00%.
Those who are shareholders of AstraZeneca until August 7, 2024 will be eligible to receive £0.776 per share on September 9, 2024.
In the latest dividend distribution, AstraZeneca paid £1.56 per share on March 25, 2024 to shareholders who owned shares before February 22, 2024.
Investors in AstraZeneca can expect dividends in February and August, as part of its semiannual payment policy.
Given that there are no dividend payments in AstraZeneca, a dividend yield is not available.
In the last fiscal year, AstraZeneca's payout ratio was 75.90%, indicating that profits adequately cover the dividend payment.
AstraZeneca has been paying dividends for only one year, which prevents considering whether its dividends are increasing.